These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4403570)

  • 1. [Electrophysiological analysis of action on the central nervous system of an antiadrenergic beta-blockade, butydrine].
    Enia F; Nigito A; D'Agostino V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(11):300-2. PubMed ID: 4403570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs].
    Mazurowa A; Szadowska A; Szmigielski A
    Kardiol Pol; 1972; 15(2):167-75. PubMed ID: 4403276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA; Schaum E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the combined use of beta-adrenergic blockade and antiarrhythmic drugs.
    Mazurowa A; Szadowska A; Szmigielski A; Litwinowicz A
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):280-7. PubMed ID: 4393014
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electroencephalographic analysis of the central action of some urea derivatives].
    Saratikov AS; Agarkova VP; Gorshkova VK
    Farmakol Toksikol; 1974; 37(6):668-71. PubMed ID: 4464092
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relation between the changes of cellular electrogenesis and beta-blocking activity of 4 optical isomers of butydrine].
    Musso E; Taccardi B
    Atti Soc Ital Cardiol; 1969 Jan; 2():268-9. PubMed ID: 5406541
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of the anti-arrhythmic activity of some beta-blocking drugs].
    Arcangeli A; Sarcinelli L; Brusadelli S
    Acta Anaesthesiol; 1968; ():Suppl 8:335+. PubMed ID: 4393552
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs.
    Allen JD; Ekue JM; Pantridge JF; Shanks RG; Zaidi SA
    Br J Anaesth; 1971 Jul; 43(7):720-1. PubMed ID: 4398093
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the antiadrenergic effect of nitroglycerine and iprazid under the conditions of neurogenic heart damage].
    Bendikov EA; Vysotkaia NB
    Farmakol Toksikol; 1968; 31(2):174-7. PubMed ID: 4970718
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurophysiologic study of the psychomotor effect of a drug: apropos of bulcocapnine catatonia].
    Borenstein P; Gekière F; Aleonard P; Gruet-Masson J; Allègre G
    Sem Hop; 1969 Apr; 45(19):1247-57. PubMed ID: 4306997
    [No Abstract]   [Full Text] [Related]  

  • 12. [The beta-adrenergic blockers as anti-arrhythmics].
    Nadal-Ginard B; Sanz G; Cárdenas M
    Arch Inst Cardiol Mex; 1970; 40(4):461-70. PubMed ID: 4394936
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative pharmacological activity of some beta-adrenoblocking agents and allied compounds].
    Gorodinskaia VIa; Simon IB
    Farmakol Toksikol; 1972; 35(1):29-33. PubMed ID: 4400981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism governing the action of sympathomimetic agents on the lymph vessels].
    Valeeva ZT
    Farmakol Toksikol; 1972; 35(3):307-9. PubMed ID: 4403056
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical pharmacology of anti-arrhythmia agents].
    Azanza Perea JR; Honorato Pérez JM; Cuena Boy R
    Rev Med Univ Navarra; 1984 Mar; 28(1):37-43. PubMed ID: 6147005
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation of the minute waves of superslow activity and hippocampal temperature in altered function of the central nervous system].
    Borodkin IuS; Lapina IA; Iaichnikov IK
    Fiziol Zh SSSR Im I M Sechenova; 1982 May; 68(5):583-90. PubMed ID: 6124463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors].
    Witkowska M
    Kardiol Pol; 1982; 25(2):147-61. PubMed ID: 6125621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta blockers and the central nervous system].
    Koella WP; Dollery CT; van Zwieten PA; Cruickshank JM; Betts TA; Harms D; Cove-Smith JR
    Med Monatsschr Pharm; 1984 Sep; 7(9):275-7. PubMed ID: 6149452
    [No Abstract]   [Full Text] [Related]  

  • 19. The nigro-neostriatal pathway: the effects produced by iontophoretic dopamine.
    Connor JD
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():193-206. PubMed ID: 4403651
    [No Abstract]   [Full Text] [Related]  

  • 20. [A neurophysiologic analysis of the central effect of the new n-cholinolytic drug IEM-506].
    Losev NA
    Farmakol Toksikol; 1972; 35(5):544-9. PubMed ID: 4652003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.